FDA applicant
Personal Genome Diagnostics, Inc.
FDA records 3 decisions for Personal Genome Diagnostics, Inc. (Baltimore, MD) from 2020 to 2026: 1 510(k) clearance, 1 De Novo grant and 1 original PMA approval. Most are in product codes PZM (Next Generation Sequencing Based Tumor…) and SBY (High Throughput Sequencing Based Tumor…). Its devices cite 1 predicate, 0 of them its own earlier devices. No recall is linked to its devices.
FDA’s records also spell it “Personal Genome Diagnostics”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Personal Genome Diagnostics, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2020.
Planning a device like Personal Genome Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Personal”
FDA records each applicant name separately; these may or may not be the same firm.